https://biotechmorning.com/news/regenxbio-brain-tumor-problem-gene-therapy-hold Biotech Morning en 2026-08-24T14:16:24.421Z Regenxbio's Brain Tumor Problem Just Got Bigger https://biotechmorning.com/news/leqembi-subcutaneous-approval-alzheimers Biotech Morning en 2026-08-24T14:15:42.920Z LEQEMBI Just Ditched the IV Pole. That Changes Everything. https://biotechmorning.com/news/lilly-foundayo-oral-weight-loss-pill-uk-launch Biotech Morning en 2026-08-24T14:14:57.805Z The Pill That Could End the Era of Weight-Loss Injections https://biotechmorning.com/news/roche-hanmi-ucn2-muscle-preserving-obesity-deal Biotech Morning en 2026-08-24T14:14:10.031Z Roche's $2.3 Billion Bet on the Muscle Problem Nobody's Solved https://biotechmorning.com/news/jj-sail-in-vivo-car-t-deal Biotech Morning en 2026-08-24T14:13:23.973Z J&J Just Dropped $785 Million on a Company That Wants to Kill the CAR-T Factory https://biotechmorning.com/news/personalized-mrna-cancer-vaccine-melanoma Biotech Morning en 2026-08-24T14:12:37.909Z The Cancer Vaccine That Knows Your Name https://biotechmorning.com/news/uk-335-million-life-sciences-bet Biotech Morning en 2026-08-24T14:11:53.914Z The UK Just Bet $335 Million That It Can Out-Science Everyone https://biotechmorning.com/news/tempus-ecg-ph-ai-pulmonary-hypertension-fda-clearance Biotech Morning en 2026-08-24T14:11:10.609Z The Heart Test Hiding in Plain Sight https://biotechmorning.com/news/braveheart-bio-ipo-382-million-cardiac-drug Biotech Morning en 2026-08-24T14:10:22.412Z A Heart Drug Startup Just Raised $382M on Day One. Wall Street Noticed. https://biotechmorning.com/news/ultragenyx-gene-therapy-replace-midnight-snack-gsdia Biotech Morning en 2026-08-24T14:09:37.388Z The Gene Therapy That Wants to Replace Your Midnight Snack https://biotechmorning.com/news/repligen-biolife-solutions-acquisition-bioprocessing Biotech Morning en 2026-08-23T14:17:58.556Z Repligen Just Bought Its Way Into Cell Therapy's Plumbing https://biotechmorning.com/news/fda-commissioner-kalvista-rare-disease-drug-rejection Biotech Morning en 2026-08-23T14:17:11.441Z The FDA Commissioner Tried to Kill a Rare Disease Drug. It Didn't Work. https://biotechmorning.com/news/lilly-ataibeckley-psychedelic-acquisition Biotech Morning en 2026-08-23T14:16:29.142Z Lilly Just Dropped $3.8 Billion on a Psychedelic Trip https://biotechmorning.com/news/moderna-merck-mrna-cancer-vaccine-melanoma-phase-3 Biotech Morning en 2026-08-23T14:15:42.324Z The Vaccine That Isn't for a Virus https://biotechmorning.com/news/australia-first-h5n1-mammal-seal Biotech Morning en 2026-08-23T14:14:55.330Z A Seal in South Australia Just Became a Pandemic Warning Sign https://biotechmorning.com/news/taiho-cullinan-lung-cancer-challenge-jj Biotech Morning en 2026-08-23T14:14:12.909Z J&J Built a Lung Cancer Empire. Two Underdogs Just Crashed the Gates. https://biotechmorning.com/news/ptc-therapeutics-fabry-disease-gene-therapy-bankruptcy Biotech Morning en 2026-08-23T14:13:27.563Z PTC Therapeutics Just Bought a Gene Therapy Out of Bankruptcy Court https://biotechmorning.com/news/eli-lilly-750m-resilience-kwikpen-manufacturing Biotech Morning en 2026-08-23T14:12:42.464Z Eli Lilly Just Dropped $750M on a Factory. The Reason? A Pen.